St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Diamond-Blackfan anemia (DBA) is a rare genetic blood disorder that occurs when the bone marrow does not make enough red blood cells. When the number of red blood cells are low, fewer red blood cells are available to deliver oxygen to the body.
DBA affects 5–7 newborn babies per 1 million worldwide and occurs equally in both boys and girls. It usually develops in the first year of life but can appear at any age.
Diamond-Blackfan anemia symptoms can be mild to severe. Sometimes there are no symptoms.
Having low red blood cells (anemia) is usually the first symptom of DBA. Other symptoms can include:
Children with DBA may also have one or more physical characteristics:
Diamond-Blackfan anemia is a genetic disorder caused by a mutation (change) in 1 of more than 30 genes. These genes are responsible for the normal function of ribosomes in the body’s cells. Ribosomes help to form proteins which are essential building blocks of the body.
The most common genes affected in DBA patients are RPS19, RPL5, RPL11, RPL35a, RPS10, RPS26 and RPS24. About 20-30% of DBA cases do not have a known genetic cause.
In many families, the gene mutation (change) that causes DBA is passed from parent to child. If one parent has the gene mutation, there is a 50% chance it will pass on to children. In at least 1 in 3 of DBA cases, the gene change is not found in either parent. It is new to the family.
Within the same family, DBA can have different symptoms. For example, one child with the gene change might have mild symptoms and not need any therapy. Another child might need blood transfusions throughout life.
Tests to diagnose DBA include:
The most common treatments for DBA are corticosteroid therapy, blood transfusions and allogeneic bone marrow transplants.
Corticosteroid therapy
Prescription steroid medicines can help bone marrow create red blood cells. Children younger than 1 year of age are not given steroids due to side effects. Some side effects can affect their growth.
Most children who take corticosteroids will show a response. This means they will have more hemoglobin and reticulocytes. Due to corticosteroid side effects, the dose must be decreased over several weeks. However, low-dose steroids must be continued long-term in order to maintain a response.
Side effects of corticosteroid treatment may include:
Blood transfusion (red blood cell transfusion)
In a blood transfusion, children get healthy red blood cells donated from another person. Transfusions can increase the number of red blood cells and hemoglobin.
Blood is given into a vein through an IV or a port, which is a tiny device placed under the skin. Transfusions are usually repeated every 3-4 weeks. Over time they can lead to an excess of iron in the body. Iron deposits in organs such as the liver, heart, and pancreas can cause damage if not removed properly. To prevent iron overload, patients often take daily medicines that help remove excess iron from the body.
Stem cell (bone marrow) transplant
A stem cell transplant replaces the unhealthy bone marrow with healthy cells from a donor. For this treatment, a suitable donor (related or unrelated) must first be identified. A stem cell transplant can cure the main effects of DBA, including anemia, for life. But in some patients, it can cause side effects. These include:
The long-term survival after transplant in children with DBA is higher than 90%.
St. Jude offers clinical trials and research studies for children, teens, and young adults with DBA. Learn more about clinical research at St. Jude.
Study goal:
The main goal of this trial is to collect DNA from individuals with non-cancerous blood diseases and their family members. Researchers will use the DNA to study how genes cause and influence these diseases. All research data will be confidential.
Children with DBA can live long lives with proper treatment.
Some people treated for DBA will achieve remission, meaning their symptoms go away for 6 months or longer. In some cases, remission can be permanent. If the disease comes back (relapse), additional transfusions may be needed. A small number of DBA patients might have cancers later in life. These include:
Children with DBA may have frequent visits to the doctor and may need hospital stays for disease complications. This may result in missed days of school and missed days of work for their caregivers. But in general, children with DBA can lead normal lives.
Patients accepted to St. Jude must have a disease we treat and must be referred by a physician or other qualified medical professional. We accept most patients based on their ability to enroll in an open clinical trial.
Call: 1-888-226-4343 (toll-free) or 901-595-4055 (local) | Fax: 901-595-4011 | Email: referralinfo@stjude.org | 24-hour pager: 1-800-349-4334